DASH hand function score at 3 months Major outcome group 1 (hand function) (scores between 0 and 100, where 0 represents no impairment in hand function and 100 represents maximum impairment in hand function)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time from completion of operation to first flatus (hours)
1 finding from 1 review
Time from completion of operation to first bowel movement (hours)
1 finding from 1 review
Time from completion of operation to resumption of regular solid food intake (hours)
1 finding from 1 review
Any drug‐related adverse events (CTCAE grade ≥ 2)
Daikenchuto showed no clear difference in any drug‐related adverse events (CTCAE grade ≥ 2) compared with control (low certainty).
1 finding from 1 review
Patient satisfaction on day of discharge (Gastrointestinal Symptom Rating Scale (GSRS))
1 finding from 1 review
Incidence ratio of any re‐interventions before leaving hospital
Daikenchuto showed no clear difference in incidence ratio of any re‐interventions before leaving hospital compared with control (moderate certainty).
1 finding from 1 review
Length of postoperative hospital stay
1 finding from 1 review
Postoperative delirium (One study used DRS, three studies used CAM and in one study diagnostic tool was not reported) Time points were up to 4 days postoperatively
It is very uncertain whether summary of findings TIVA changes postoperative delirium (One study used DRS, three studies used CAM… compared with inhalational maintenance of anaesthesia (very low certainty).
1 finding from 1 review
Postoperative cognitive dysfunction (9 studies used MMSE, and 2 of these studies used additional diagnostic tools; 1 study used Trail Making Test and additional diagnostic tools; 3 studies did not report diagnostic tools) Time points were up to 30...
Summary of findings TIVA may leads to lower postoperative cognitive dysfunction (9 studies used MMSE, and 2 of… compared with inhalational maintenance of anaesthesia (low certainty).
1 finding from 1 review
Mortality at 30 days
It is very uncertain whether summary of findings TIVA changes mortality At 30 days compared with inhalational maintenance of anaesthesia (very low certainty).
1 finding from 1 review
Intraoperative hypotension (defined by study authors as change in MAP from baseline)
1 finding from 1 review
Length of stay in PACU
1 finding from 1 review
Length of hospital stay
1 finding from 1 review
Intervention not reported
Serious adverse events – not reported · people with a low platelet count
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Outcomes ( · women with posterior vaginal wall prolapse
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Awareness of prolapse (subjective failure) (16‐24 months) · women with posterior vaginal wall prolapse
Biological graft showed no clear difference in awareness of prolapse (subjective failure) (16‐24 months) compared with native tissue repair (moderate certainty).
1 finding from 1 review
Recurrent posterior vaginal wall prolapse (objective failure) (12‐25 months) · women with posterior vaginal wall prolapse
Biological graft showed no clear difference in recurrent posterior vaginal wall prolapse (objective failure) (16‐24… compared with native tissue repair (low certainty).
1 finding from 1 review
Postoperative obstructed defecation (16‐24 months) · women with posterior vaginal wall prolapse
Biological graft showed no clear difference in postoperative obstructed defecation (16‐24 months) compared with native tissue repair (moderate certainty).
1 finding from 1 review
Postoperative dyspareunia (12‐25 months) · women with posterior vaginal wall prolapse
Biological graft showed no clear difference in postoperative dyspareunia (16‐24 months) compared with native tissue repair (low certainty).
1 finding from 1 review